Prospective, Non-interventional, Multicenter Study to Evaluate QoL and Influence of Cognitive Status on QoL in Patients With RRMS During 2 Years Treatment With RNF.
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2016
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms MusiClock
- Sponsors Merck KGaA
- 31 Jan 2014 According to ClinicalTrials.gov record trial status changed from active, no longer recruiting to completed.
- 12 Feb 2013 Planned End Date changed from 1 Oct 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 12 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.